Bioactive Compounds
-
B6643 2-APBSummary: antagonist of Ins(1,4,5) P3-induced Ca2+ release -
B6650 CCMQSummary: inhibits [3H]-homoquinolinic acid binding to non-NMDA sensitive sites -
B6677 CI 966 hydrochlorideSummary: GABA transporter GAT-1 inhibitor -
B6948 PNU 37883 hydrochlorideSummary: Kir6 (KATP) channel antagonist -
B7144 PHTPPSummary: estrogen ERβ receptor antagonist -
B7314 XACSummary: Adenosine receptor antagonist -
B7652 A 582941Summary: partial agonist of α7 nicotinic acetylcholine receptors -
B1772 Ibandronate sodiumTarget: Bone resorptionSummary: Potent bisphosphonate drug -
B1805 Oxybuprocaine HClSummary: Local anesthetic -
B1354 Bisoprolol fumarateSummary: Selective α-adrenergic blocker

